Commonwealth Equity Services
GNOM icon

Commonwealth Equity Services’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Commonwealth Equity Services’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$220K Buy
+3,128
New +$191K ﹤0.01% 3998
2024
Q3 		– Sell
-2,536
Closed -$106K – 4124
2024
Q2 		$106K Sell
2,536
-1
-0% -$42 ﹤0.01% 3803
2024
Q1 		$115K Buy
+2,537
New +$116K ﹤0.01% 3769
2021
Q4 		– Sell
-2,407
Closed -$213K – 3685
2021
Q3 		$213K Buy
+2,407
New +$226K ﹤0.01% 3226
2021
Q2 		– Sell
-5,769
Closed -$518K – 3549
2021
Q1 		$518K Buy
+5,769
New +$569K ﹤0.01% 2307

Other funds holding GNOM

LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Wealth Management Partners
Wealth Management Partners Tucson, Arizona $426M AUM 43.17% 1-Year Est. Return
Oppenheimer Asset Management
Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return
Polaris Financial Partners
Polaris Financial Partners Westerville, Ohio $223M AUM
Creative Financial Designs
Creative Financial Designs Kokomo, Indiana $2.22B AUM 15.38% 1-Year Est. Return
Sightline Wealth Advisors
Sightline Wealth Advisors Groton, Connecticut $215M AUM 10.46% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
J.W. Cole Advisors
J.W. Cole Advisors Tampa, Florida $5.93B AUM 23.96% 1-Year Est. Return
Armis Advisers
Armis Advisers Atlanta, Georgia $1.2B AUM 15.74% 1-Year Est. Return

Commonwealth Equity Services's GNOM Position: Q3 2026 in Review

Commonwealth Equity Services opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q3 2026: 3,128 shares worth $220K. The stake represents ﹤0.01% of the portfolio and ranks #3998 among its holdings. This is a return to the name: Commonwealth Equity Services previously reported a position in GNOM as recently as Q2 2024.

Commonwealth Equity Services first reported a position in GNOM in Q1 2021 and has held it in 5 quarters since. The position peaked at $518K in Q1 2021. 28 funds tracked by Wall St. Rank hold GNOM as of Q3 2026.

  • Commonwealth Equity Services held 3,128 shares of Global X Genomics & Biotechnology ETF worth $220K as of Q3 2026.
  • Global X Genomics & Biotechnology ETF was a new Commonwealth Equity Services position in Q3 2026.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q3 2026, its #3998 holding.
  • Commonwealth Equity Services first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and has held it in 5 quarters since.
  • Commonwealth Equity Services's Global X Genomics & Biotechnology ETF position peaked at $518K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2026.

Based on Commonwealth Equity Services's 13F filing for Q3 2026, filed 2 Nov 2026.